Ionis Pharmaceuticals, Inc.
IONS
Xếp hạng trong cổ phiếu
#2646
Founded in 1989 and headquartered in Carlsbad, California, Ionis... Founded in 1989 and headquartered in Carlsbad, California, Ionis Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapies within the United States. Its commercial portfolio includes three key medications: SPINRAZA, prescribed for spinal muscular atrophy (SMA) in both children and adults; TEGSEDI, an injectable treatment targeting polyneuropathy associated with hereditary transthyretin-mediated amyloidosis in adult patients; and WAYLIVRA, which addresses familial chylomicronemia syndrome and familial partial lipodystrophy. Ionis also maintains a robust pipeline, with several drug candidates currently in Phase 3 clinical trials. These include Eplontersen, a monthly self-administered subcutaneous injection designed for all forms of TTR amyloidosis; Olezarsen, intended for individuals with severe hypertriglyceridemia (SHTG); Donidalorsen, for patients suffering from hereditary angioedema; ION363, aimed at amyotrophic lateral sclerosis (ALS); Pelacarsen, developed for those with established cardiovascular disease and elevated lipoprotein(a); and Tofersen, which works by inhibiting the production of superoxide dismutase 1. Beyond these late-stage assets, the company is actively researching treatments for metabolic, infectious, renal, and ophthalmic diseases, as well as various types of cancer. The firm engages in significant collaborations, notably a strategic partnership with Biogen Inc. Additionally, it holds licensing and collaboration agreements with AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis AG, Roche, Janssen Biotech, Inc., and Flamingo Therapeutics, Inc.
Giá cổ phiếu
$43.35
Vốn hóa thị trường
$7.20B
Thay đổi (1 ngày)
0.94%
Thay đổi (1 năm)
-40.70%
Quốc gia
US
Giao dịch Ionis Pharmaceuticals, Inc. (IONS)
Danh mục
Healthcare
EPS của Ionis Pharmaceuticals, Inc. (IONS)
EPS tính đến June 2026 TTM: $-3.46
Theo các báo cáo tài chính mới nhất và giá cổ phiếu của Ionis Pharmaceuticals, Inc., EPS hiện tại của công ty (TTM) là $-3.46. Vào cuối năm 2023, công ty có EPS là $-2.56, tăng so với EPS năm 2022 là $-1.90.
Lịch sử EPS của Ionis Pharmaceuticals, Inc. từ 2000 đến 2026
EPS vào cuối mỗi năm
| Năm | EPS | Thay đổi |
|---|---|---|
| 2026 (TTM) | $-3.46 | 13.82% |
| 2024 | $-3.04 | 18.75% |
| 2023 | $-2.56 | 34.74% |
| 2022 | $-1.90 | 850.00% |
| 2021 | $-0.20 | -93.71% |
| 2020 | $-3.18 | -251.43% |
| 2019 | $2.10 | 1.45% |
| 2018 | $2.07 | -4,403.53% |
| 2017 | $-0.05 | -93.32% |
| 2016 | $-0.72 | -2.70% |
| 2015 | $-0.74 | 124.24% |
| 2014 | $-0.33 | -40.00% |
| 2013 | $-0.55 | -15.38% |
| 2012 | $-0.65 | -23.53% |
| 2011 | $-0.85 | 37.10% |
| 2010 | $-0.62 | -139.24% |
| 2009 | $1.58 | -1,315.38% |
| 2008 | $-0.13 | 0.00% |
| 2007 | $-0.13 | -79.03% |
| 2006 | $-0.62 | -46.09% |
| 2005 | $-1.15 | -54.37% |
| 2004 | $-2.52 | 47.37% |
| 2003 | $-1.71 | 28.57% |
| 2002 | $-1.33 | -20.36% |
| 2001 | $-1.67 | 15.97% |
| 2000 | $-1.44 | 0.00% |
EPS cho các công ty hoặc đối thủ cạnh tranh tương tự
| Công ty | EPS | Chênh lệch EPS | Quốc gia |
|---|---|---|---|
| $17.32 | -600.58% |
US
|
|
| $-7.98 | 130.64% |
US
|
|
| $-5.29 | 52.89% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -901.73% |
NL
|
